Propylidynetrimethanol, ethoxylated, propoxylated, esters with acrylic acid (<6.5 mol EO and <6.5 mol PO)

Skin sensitisation

Administrative data

Endpoint:

skin sensitisation: in vivo (LLNA)

Type of information:

experimental study

Adequacy of study:

key study

Study period:

05 October 2011 to 02 November 2011

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

guideline study

Data source

Reference

Reference 1

Reference Type:

study report

Title:

Unnamed

Year:

2012

Report date:

2012

Reference 2

Reference Type:

other: Amendment

Title:

Unnamed

Year:

2012

Report date:

2012

Materials and methods

Test guideline

Qualifier:

according to guideline

Guideline:

OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)

Version / remarks:

24 April 2002

Deviations:

no

GLP compliance:

yes (incl. QA statement)

Type of study:

mouse local lymph node assay (LLNA)

Test material

Test material information

Constituent 1

Reference substance name:

Propylidynetrimethanol, ethoxylated, propoxylated, esters with acrylic acid (<6.5 mol EO and <6.5 mol PO)

EC Number:

701-361-3

Molecular formula:

C6 H14 O3 . 3 (C3 H6 O . C2 H4 O)x . x C3 H4 O2

IUPAC Name:

Propylidynetrimethanol, ethoxylated, propoxylated, esters with acrylic acid (<6.5 mol EO and <6.5 mol PO)

Specific details on test material used for the study:

Batch No.: 110007P040

In vivo test system

Test animals

Species:

mouse

Strain:

CBA/Ca

Sex:

female

Details on test animals and environmental conditions:

TEST ANIMALS
- Source: CBA/CaOlaHsd: Harlan Laboratories, Horst, Netherlands; CBA/CaCrl: Charles River UK
- Age at study initiation: 9-11 weeks
- Weight at study initiation: 17.4 - 21.6g
- Housing: groups in Makrolon Type II (pretest) or Type III (main study) cages
- Diet: Pelleted standard diet ad lib. (Harlan laboratories, Horst, Netherlands) ad libitum
- Water: tap water ad lib.
- Acclimation period: at least 5 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22±2°C
- Humidity (%): 45-65% (main study)
- Photoperiod (hrs dark / hrs light): 12h/12h

Study design: in vivo (LLNA)

Vehicle:

acetone/olive oil (4:1 v/v)

Concentration:

0%, 1.19%, 2,94%, 6.0% (w/w) (main study - concentration was corrected according to sample analysis)
50%, 100% (1st pre-test)
10%, 25% (2nd pre-test)
2.5%, 5% (3rd pre-test)

No. of animals per dose:

5 (main study)
2 (for each pre-tests)

Details on study design:

RANGE FINDING TESTS:
- Compound solubility: soluble in aceton:olive oil (4:1 v/v)
- Irritation: considered excessive, if erythema ≥3 at any time point or increase in ear thickness ≥ 25% on day 3 or 6
50% / 100% (1st pretest): erythema up to grade 2 and ear swelling of 51% and 81%.
10% / 25% (2nd pretest): erythema up to grade 2 and ear swelling of 33.3% and 102.1%
2.5% / 5% (3rd pretest): erythema grade 1 (day 4-6), only slight ear swelling (app. 8%)
- Lymph node proliferation response: not measured in pretests

MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: LLNA
- Criteria used to consider a positive response: SI value ≥ 3 and dose response relationship is observed, though local effects or immunological suppression must also be considered.

TREATMENT PREPARATION AND ADMINISTRATION:
25 µL of each concentration was spread evenly onto the dorsal surface of each ear on three consecutive days.
5 days after the first application 250 µL of phosphate-buffered saline (PBS) containing 20.0 µCi of ³HTdR (equivalent to approximately 79.9 µCi/mL ³HTdR) were injected into each test and control mouse via the tail vein. Mice were euthanised 5 hours later.

Positive control substance(s):

hexyl cinnamic aldehyde (CAS No 101-86-0)

Statistics:

A One-Way-Analysis-of-Variance was used as statistical method. In case of significant results of the One-Way-ANOVA, multiple comparisons were performed with the Dunnett test. Statistical significance was set at the five per cent level (p < 0.05). The Dean-Dixon-Test was used for identification of possible outliers.

Results and discussion

Positive control results:

SI (10%) = 2.18
SI (25%) = 8.08
EC3 = 12.1%
historical control data: SI (25%) = 5.04 - 10.03

In vivo (LLNA)

Results

Results 1

Key result

Parameter:

SI

Value:

0.88

Test group / Remarks:

1 % test item

Results 2

Key result

Parameter:

SI

Value:

0.87

Test group / Remarks:

2.5 % test item

Results 3

Key result

Parameter:

SI

Value:

1.84

Test group / Remarks:

5% test item

Cellular proliferation data / Observations:

CELLULAR PROLIFERATION DATA
The measured lymph node weights and –cell counts of all animals treated were recorded after sacrifice. No statistically significant increase in lymph node weight was observed in any of the test item treated groups in comparison to the vehicle control group. A statistically significant increase was determined for the lymph node cell counts in the high dose group (p<0.05). The cutoff-value for a positive response regarding the lymph node cell count index of 1.55 reported for BALB/c mice was not exceeded in any group.

DETAILS ON STIMULATION INDEX CALCULATION
The proliferative response of the lymph node cells is expressed as the number of radioactive disintegrations per minute per lymph nodes of each animal (DPM/animal) and as the ratio of 3HTdR incorporated into lymph node cells of lymph nodes of test animals relative to that recorded for lymph nodes of control animals (Stimulation Index; S.I.). Before DPM/animal values were determined, mean scintillation-background DPM was subtracted from test and control raw data.

EC3 CALCULATION
The EC3 value could not be calculated, since all S.I.´s are below 3.

CLINICAL OBSERVATIONS:
No symptoms of local toxicity at the ears of the animals and no systemic findings were observed during the study period.

BODY WEIGHTS
The body weight of the animals, recorded prior to the first application and prior to treatment with 3HTdR, was within the range commonly recorded for animals of this strain and age.

Applicant's summary and conclusion

Interpretation of results:

GHS criteria not met